O. V. Romanchuk

Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report

S. Orlov, Pavel L. Baldin, Natalia V. Diuzeva, 2022, Journal of Modern Oncology.

Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study

L. Bolotina, M. Fael, E. Kovalenko, 2021, Meditsinskiy sovet = Medical Council.

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia

L. Bolotina, V. Gorbunova, E. Ovchinnikova, 2019, Journal of Modern Oncology.

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

F. Moiseenko, O. Kit, D. Nosov, 2019, Medical Council.

“Watch and wait” approach in the treatment of advanced radioiodine refractory differentiated thyroid cancer: a study of barriers and drivers of use

S. Podvyaznikov, A. Shurinov, E. Borodavina, 2024, Head and Neck Tumors (HNT).